Skip to main content
. 2026 Jul 14;18(7):857. doi: 10.3390/pharmaceutics18070857
ACTA2 Alpha-smooth muscle actin
Alix ALG-2 interacting protein
AMD Age-related macular degeneration
BMDM Bone marrow-derived macrophages
CD Cluster of differentiation
CNS Central nervous system
CuAAC Copper-catalyzed azide-alkyne cycloaddition
CXCL10 C-X-C motif chemokine ligand 10
DC Dendritic cell
DC-STAMP Dendritic cell-specific transmembrane protein
ECM Extracellular matrix
EV Extracellular vesicle
FDA U.S. Food and Drug Administration
FGF Fibroblast growth factor
FLS Fibroblast-like synoviocyte
GAP-43 Growth-associated protein-43
GFAP Glial fibrillary acidic protein
HHP High-hydrostatic pressure
Hsp70 Heat shock protein 70
HUVEC Human umbilical vein endothelial cells
IFN-α Interferon-alpha
IGF-1 Insulin-like growth factor-1
IL-33 Interleukin-33
LPS Lipopolysaccharide
MBV Matrix-bound nanovesicle
MCP-3 Monocyte chemotactic protein 3
MECM ECM-educated macrophage phenotype
miRNA microRNA
MISEV Minimal Information for Studies of Extracellular Vesicles
MSC Mesenchymal stem cell
NFATc1 Nuclear factor of activated T-cells, cytoplasmic 1
NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
NTA Nanoparticle tracking analysis
PEG Poly(ethylene glycol)
RANKL Receptor activator of nuclear factor kappa-B ligand
RGC Retinal ganglion cell
RPE Retinal pigment epithelium
SEC Size-exclusion chromatography
siRNA Small interfering RNA
SIS Small intestinal submucosa
SPAAC Strain-promoted alkyne-azide cycloaddition
ST2 Suppression of tumorigenicity 2
TEM Transmission electron microscopy
TGF-β1 Transforming growth factor beta 1
TSG101 Tumor susceptibility gene 101
UBM Urinary bladder matrix
VFLP Vocal fold lamina propria